Güntülü ŞIK, Asuman DEMİRBUĞA, Agageldi ANNAYEV, Bahar TEMUR, Yavuz Selim AYDIN, Halil İbrahim DEMİR, Ersin EREK, Agop ÇITAK

Clinical and laboratory predictors of survival for pediatric patients on non-postcardiotomy extracorporeal membrane oxygenation (ECMO)

Extracorporeal membrane oxygenation (ECMO) is used in pediatric patients with severe cardiopulmonary failure who do not respond to conventional therapy; only a few studies have been conducted in Turkey. We present the experience of pediatric ECMO with the aim of showing factors affecting mortality. We retrospectively reviewed our ECMO database to identify patients who received ECMO from October 2015 to March 2018. Our population comprised 30 pediatric patients. The mean patient age was 41.31±53.35 months and 17 (56.7%) patients were male. The median duration of ECMO support was 8.9 (6.6-10.8) days. The rates of successful ECMO weaning and survival to discharge were 70.0% (n=21) and 66.7% (n=20), respectively. Indications for ECMO were respiratory failure (40.0%), cardiac failure (33.3%), and sepsis (26.7%). We found that pre-cannulation values of pH (p=0.034), leukocytes (p=0.029), C-reactive protein (p=0.045), creatinine (p=0.047), chloride (p=0.001) and post-cannulation pH (p=0.0001), bicarbonate (p=0.014), lactate (p=0.002), chloride (p=0.0001) were associated with mortality. The results showed that preexisting sepsis and renal conditions contributed to poor outcomes. Indications, ECMO onset time, and pre- and post-cannulation laboratory values such as leukocytes, CRP, creatinine, bicarbonate, lactate, and chloride are factors that affect outcomes.

PDF

___

1.Baffes TG, Fridman JL, Bicoff JP, Whitehill JL. Extracorporeal circulation for support of palliative cardiac surgery in infants. Ann Thorac Surg 1970; 10: 354-363.

2.Bartlett RH, Gazzaniga AB, Huxtable RF, Schippers HC, O’Connor MJ, Jefferies MR. Extracorporeal circulation (ECMO) in neonatal respiratory failure. J Thorac Cardiovasc Surg 1977; 74: 826-833.

3.Fuchs A, Netz H. Ventricular assist devices in pediatrics. Images Paediatr Cardiol 2001; 3: 24-54.

4.Aharon AS, Drinkwater DC Jr, Churchwell KB, et al. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann Thorac Surg 2001; 72: 2095-2101.

5.Alsoufi B, Al-Radi OO, Gruenwald C, et al. Extra-corporeal life support following cardiac surgery in children: analysis of risk factors and survival in a single institution. Eur J Cardiothorac Surg 2009; 35: 1004-1011.

6.Barbaro RP, Paden ML, Guner YS, et al; on behalf of the ELSO member centers. Pediatric Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J 2017; 63: 456-463.

7.Carpenter JL, Yu YR, Cass DL, et al. Use of venovenous ECMO for neonatal and pediatric ECMO: a decade of experience at a tertiary children's hospital. Pediatr Surg Int 2018; 34: 263-268.

8.Kim H, Yang JH, Cho YH, Jun TG, Sung K, Han W. Outcomes of extracorporeal membrane oxygenation in children: an 11-year single-center experience in Korea. Korean J Thorac Cardiovasc Surg 2017; 50: 317-325.

9.Joffe AR, Leguier L, Robertson CM. Pediatric outcomes after extracorporeal membrane oxygenation for cardiac disease and for cardiac arrest: a review. ASAIO J 2012; 58: 297-310.

10.Thourani VH, Kirsbom PM, Kanter KR, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg 2006; 82: 138-144.

11.Formica F, Avalli L, Colagrande L, et al. Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 2010; 10: 721-726.

12.Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: a retrospective observational study. J Thorac Cardiovasc Surg 2015; 149: 1445-1450.

13.Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36: 1404-1411.

14.Hsu PS, Chen JL, Hong GJ, et al. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg 2010; 37: 328-333.

15.Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004; 77: 151-157.

16.Francischetti IMB, Szymanski J, Rodriguez D, Heo M, Wolgast LR. Laboratory and clinical predictors of 30- day survival for patients on extracorporeal membrane oxygenation (ECMO): 8-year experience at Albert Einstein College of Medicine, Montefiore Medical Center. J Crit Care 2017; 40: 136-144.

17.Yunos NM, Bellomo R, Story D, Kellum J. Bench-to-bedside review: chloride in critical illness. Crit Care 2010; 14: 226.

18.Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Crit Care 2010; 14: 325.

19.Soussi S, Ferry A, Chaussard M, Legrand M. Chloride toxicity in critically ill patients: what's the evidence? Anaesth Crit Care Pain Med 2016; 36: 125-130.

20.Tani M, Morimatsu H, Takatsu F, Morita K. The incidence and prognostic value of hypochloremia in critically ill patients. ScientificWorldJournal 2012; 2012: 474185.

21.Distelmaier K, Roth C, Binder C, et al. Urinary output predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery. Crit Care Med 2016; 44: 531-538.

22.Loforte A, Marinelli G, Musumeci F, et al. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors. Artif Organs 2014; 38: E129-E141.

23.Kumar TK, Zurakowski D, Dalton H, et al. Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg 2010; 140: 330-336.e2.

24.Chow G, Koirala B, Armstrong D, et al. Predictors of mortality and neurological morbidity in children undergoing extracorporeal life support for cardiac disease. Eur J Cardiothorac Surg 2004; 26: 38-43.

25.Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med 2005; 33: 2817-2824.

26.Nunez Lopez O, Cambiaso-Daniel J, Branski LK, Norbury WB, Herndon DN. Predicting and managing sepsis in burn patients: current perspectives. Ther Clin Risk Manag 2017; 13: 1107-1117.

27.Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 426-435.

28.Wang C, Gao L, Zhang ZG, et al. Procalcitonin is a stronger predictor of long-term functional outcome and mortality than high-sensitivity C-reactive protein in patients with ischemic stroke. Mol Neurobiol 2016; 53: 1509-1517.

29.Siddigui I, Jafri L, Abbas Q, Reheem A, Haque A. Relationship of serum procalcitonin, C-reactive protein, and lactic acid to organ failure and outcome in critically ill pediatric population. Indian J Crit Care Med 2018; 22: 91-95.

30.Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiraty failure: survival and predictors of mortality. Crit Care Med 2011; 39: 364-370.

31.Skinner SC, Iocono JA, Ballard HO, et al. Improved survival in venovenous vs venoarterial extracorporeal membrane oxygenation for pediatric noncardiac sepsis patients: a study of the Extracorporeal Life Support Organization Registry. J Pediatr Surg 2012; 47: 63-67.

32.Gupta M, Shanley TP, Moler FW. Extracorporeal life support for severe respiratory failure in children with immune compromised conditions. Pediatr Crit Care Med 2008; 9: 380-385.

33.Steimer DA, Hernandez O, Mason DP, Schwartz GS. Timing of ECMO initiation impacts survival in influenza-associated ARDS. Thorac Cardiovasc Surg 2019; 67: 212-215.

34.Liao XZ, Zhou ZB, Cheng Z, et al. The prognostic risk factors of ECMO in patients with cardiogenic shock: a retrospective cohort analysis. Heart Surg Forum 2017; 20: E170-E177.